RxDoctor Payments Data

Abdulla Hafeez

Geriatric Medicine · Dearborn, MINPI 1265663751

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $709, 4.9 times the $143 reported in 2019.

$1,593in general payments, 2019–2025

Across 18 payments — averaging $88.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aimmune Therapeutics, Inc.$268
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$259
  • Pharmacosmos Therapeutics Inc.$231
  • Daiichi Sankyo Inc.$229
  • Axsome Therapeutics, Inc.$204
  • Otsuka America Pharmaceutical, Inc.$143
  • plus $260 from 4 others

What the payments were for

  • Food & beverage$1,593100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,593 in reported general payments places this provider in the 85th percentile of 168 geriatric medicine providers in Michigan.

See all geriatric medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$363,847
Medicare patients
696
Services billed
4,410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban73$43,371
Buprenorphine16$3,253
Lurasidone Hcl16$2,611
Ziprasidone Hcl13$2,149
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen83$1,474
Atorvastatin Calcium95$925
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen46$820
Levothyroxine Sodium78$709
Donepezil Hcl32$681
Pantoprazole Sodium54$536
Quetiapine Fumarate31$477
Mirtazapine26$475
Oxycodone Hcl30$459
Furosemide70$408
Gabapentin63$406

Paid to pharmacies, not to this prescriber.

Other geriatric medicine in Dearborn

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →